Telmisartan, Ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial

被引：0
作者：
Lyakishev, A. A.
机构：
来源：
KARDIOLOGIYA | 2008年 / 48卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 12 条
  • [1] De Giorgio L, 2000, NEW ENGL J MED, V342, P1376
  • [2] Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:: a systematic overview of data from individual patients
    Flather, MD
    Yusuf, S
    Kober, L
    Pfeffer, M
    Hall, A
    Murray, G
    Torp-Pedersen, C
    Ball, S
    Pogue, J
    Moyé, L
    Braunwald, E
    [J]. LANCET, 2000, 355 (9215) : 1575 - 1581
  • [3] Fox KM, 2003, LANCET, V362, P782
  • [4] Gerstein HC, 2000, LANCET, V355, P253
  • [5] MCMURRAY JJV, 2008, N ENGL J MED, V358
  • [6] *ONTARGET INV, 2008, N ENGL J MED, V358
  • [7] EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION - RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL
    PFEFFER, MA
    BRAUNWALD, E
    MOYE, LA
    BASTA, L
    BROWN, EJ
    CUDDY, TE
    DAVIS, BR
    GELTMAN, EM
    GOLDMAN, S
    FLAKER, GC
    KLEIN, M
    LAMAS, GA
    PACKER, M
    ROULEAU, J
    ROULEAU, JL
    RUTHERFORD, J
    WERTHEIMER, JH
    HAWKINS, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (10) : 669 - 677
  • [8] Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction - A quantitative review of data from randomized clinical trials
    Phillips, Christopher O.
    Kashani, Amir
    Ko, Dennis K.
    Francis, Gary
    Krumholz, Harlan M.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (18) : 1930 - 1936
  • [9] Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating Telmisartan, Ramipril, and their combination in high-risk patients: The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials
    Teo, KK
    [J]. AMERICAN HEART JOURNAL, 2004, 148 (01) : 52 - 61
  • [10] EFFECT OF ENALAPRIL ON SURVIVAL IN PATIENTS WITH REDUCED LEFT-VENTRICULAR EJECTION FRACTIONS AND CONGESTIVE-HEART-FAILURE
    YUSUF, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) : 293 - 302
12